"Vitiligo" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
Descriptor ID |
D014820
|
MeSH Number(s) |
C17.800.621.440.895
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vitiligo".
Below are MeSH descriptors whose meaning is more specific than "Vitiligo".
This graph shows the total number of publications written about "Vitiligo" by people in this website by year, and whether "Vitiligo" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2013 | 2 | 0 | 2 |
2014 | 1 | 0 | 1 |
2015 | 2 | 0 | 2 |
2017 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vitiligo" by people in Profiles.
-
This Month in JAAD: June 2021. J Am Acad Dermatol. 2021 06; 84(6):1542.
-
Antigen Specificity Enhances Disease Control by Tregs in Vitiligo. Front Immunol. 2020; 11:581433.
-
Replenishing Regulatory T Cells to Halt?Depigmentation in Vitiligo. J Investig Dermatol Symp Proc. 2017 10; 18(2):S38-S45.
-
Tumour necrosis factor-a inhibition can stabilize disease in progressive vitiligo. Br J Dermatol. 2015 Sep; 173(3):641-50.
-
CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo. J Invest Dermatol. 2015 Jun; 135(6):1574-1580.
-
Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. Pigment Cell Melanoma Res. 2014 Nov; 27(6):1075-85.
-
A quantitative increase in regulatory T cells controls development of vitiligo. J Invest Dermatol. 2014 May; 134(5):1285-1294.
-
Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med. 2013 Feb 27; 5(174):174ra28.
-
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest. 2007 Aug; 117(8):2197-204.
-
Report of a child with vitiligo and Evans syndrome. J Pediatr Hematol Oncol. 2003 Apr; 25(4):344-5.